Genotype-phenotype correlation in vanishing white matter disease

Neurology

Volumn 75, Issue 17, 2010, Pages 1555-1559

  Van Der Lei, H D W ^a   Van Berkel, C G M ^a   Van Wieringen, W N ^a   Brenner, C ^b   Feigenbaum, A ^c   Mercimek Mahmutoglu, S ^d   Philippart, M ^e   Tatli, B ^f   Wassmer, E ^g   Scheper, G C ^a   Van Der Knaap, M S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ISTANBUL UNIVERSITY   (Turkey)

^g BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMOBILIZATION; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET AGE; PRIORITY JOURNAL; VANISHING WHITE MATTER; WHITE MATTER;

ADULT; CROSS-SECTIONAL STUDIES; EUKARYOTIC INITIATION FACTOR-2B; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEREDITARY CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES; HUMANS; LEUKOENCEPHALOPATHIES; MALE; NERVE FIBERS, MYELINATED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 78149275114     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f962ae     Document Type: Article

References (24)

1. Van der Knaap MS, Barth PG, Gabreëls FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997;48:845-855.
2. Van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998;51:540-547.
3. Schiffmann R, Moller JR, Trapp BD, et al. Childhood ataxia with diffuse central nervous hypomyelination. Ann Neurol 1994;35:331-340.
4. Van der Knaap MS, Van Berkel GM, Herms J, et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 2003;73:1199-1207.
5. Leegwater PA, Vermeulen G, Könst AA, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 2001;29:383-388.
6. Van der Knaap MS, Leegwater PA, Könst AA, et al. Mutations in each of the fine subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002;51:264-270.
7. Hanefeld F, Holzbach U, Kruse B, Wilichowski E, Christen HJ, Frahm J. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993;24:244-248.
8. Vermeulen G, Seidl R, Mercimek-Mahmutoglu S, Rotteveel JJ, Scheper GC, van der Knaap MS. Fright is a provoking factor in vanishing white matter disease. Ann Neurol 2005;57:560-563.
9. Sonenberg N, Hershey JW, Merrick WC. Translational Control of Gene Expression, 1st ed. New York: CSHL Press; 2000.
10. Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans 2005;33:1487-1492.
11. Black DB, Harris R, Schiffmann R, Wong K Fatal infantile leukodystrophy: a severe variant of CACH/VWM syndrome, allelic to chromosome 3q27. Neurology 2002;58:161-162.
12. Fogli A, Wong K, Eymard-Pierre E, et al. Cree leukoencephalopathy and CACH/VWM disease are allelic at EIF2B5 locus. Ann Neurol 2002;52:506-510.
13. Prass K, Brück W, Schroder NW, et al. Adult-onset leukoencephalopathy with vanishing white matter presenting with dementia. Ann Neurol 2001;50:665-668.
14. Biancheri R, Rossi A, Di Rocco M, et al. Leukoencephalopathy with vanishing white matter: an adult onset case. Neurology 2003;61:1818-1819.
15. Van der Knaap MS, Leegwater PAJ, van Berkel CGM, et al. Arg113His mutation in eIF2Be as cause of leukoencephalopathy in adults. Neurology 2004;62:1598-1600.
16. Fogli A, Schiffmann R, Bertini E, et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 2004;62:1509-1517.
17. Ohtake H, Shimohata T, Terajima K, et al. Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology 2004;62:1601-1603.
18. Damon-Perriere N, Menegon P, Olivier A, et al. Intrafamilial heterogeneity in adult onset vanishing white matter disease. Clin Neurol Neurosurg 2008;110:1068-1071.
19. Labauge P, Horzinski L, Ayrignac X, et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 2009;132:2161-2169.
20. Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev 2006;12:123-128.
21. Ohlenbusch A, Henneke M, Brockmann K, et al. Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat 2005;25:411.
22. Fogli A, Boespflug-Tanguy O. The large spectrum of eIF2B-related disorders. Biochem Soc Trans 2006;34:22-29.
23. Scali O, Di Perri C, Federico A. The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci 2006;27:271-277.
24. Maletkovic J, Schiffmann R, Gorospe JR, et al. Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol 2008;23:205-215.